Junior doctors' attitudes to opioids for refractory breathlessness in patients with advanced chronic obstructive pulmonary disease
- PMID: 28585274
- DOI: 10.1111/imj.13521
Junior doctors' attitudes to opioids for refractory breathlessness in patients with advanced chronic obstructive pulmonary disease
Abstract
Background: Refractory breathlessness is a common, distressing symptom in patients with advanced chronic obstructive pulmonary disease (COPD). The judicious, off-licence prescription of opioids, together with other management strategies, can improve breathlessness, however, internationally there is profound reluctance to prescribe opioids for breathlessness in COPD.
Aims: To understand Australian junior doctors' knowledge and attitudes regarding the management of refractory breathlessness and the role of opioids in COPD.
Methods: All junior doctors undertaking basic training in internal medicine in Victoria were invited to complete an online survey. Knowledge, willingness, and experience prescribing opioids to COPD patients with refractory breathlessness, were examined.
Results: Of the 243 responses received, most trainees (193, 86.5%) believed opioids have a role in treating refractory breathlessness in stable COPD outpatients, with 143 (64.1%) recommending morphine as first-line treatment for refractory breathlessness. One quarter (55, 24.7%) reported having themselves initiated an opioid and 102 (45.7%) had prescribed an opioid under senior supervision for management of breathlessness in COPD. Concern regarding adverse opioid effects was low, with 58 (26.0%) having no concerns prescribing an opioid to COPD patients.
Conclusion: This is the first study of doctors to demonstrate high awareness, confidence, willingness and experience in prescribing opioids for the off-licence indication of refractory breathlessness in COPD. These findings differ significantly from attitudes reported overseas and are unexpected given the doctors surveyed were recently qualified. The low awareness of possible adverse events and limited insight regarding knowledge gaps is concerning and highlights the significant need for greater education in palliative care.
Keywords: COPD; attitude; dyspnoea; opioid; survey.
© 2017 Royal Australasian College of Physicians.
Comment in
-
The strength of evidence: low dose morphine for chronic breathlessness.Intern Med J. 2018 Jan;48(1):102-103. doi: 10.1111/imj.13660. Intern Med J. 2018. PMID: 29314519 No abstract available.
-
Author reply.Intern Med J. 2018 Apr;48(4):486-487. doi: 10.1111/imj.13758. Intern Med J. 2018. PMID: 29623990 No abstract available.
Similar articles
-
Prevalence and management of chronic breathlessness in COPD in a tertiary care center.BMC Pulm Med. 2019 May 16;19(1):95. doi: 10.1186/s12890-019-0851-5. BMC Pulm Med. 2019. PMID: 31096982 Free PMC article.
-
Attitudes toward opioids for refractory dyspnea in COPD among Dutch chest physicians.Chron Respir Dis. 2015 May;12(2):85-92. doi: 10.1177/1479972315571926. Epub 2015 Feb 12. Chron Respir Dis. 2015. PMID: 25676931
-
Differing Approaches to Managing the Chronic Breathlessness Syndrome in Advanced COPD: A Multi-National Survey of Specialists.COPD. 2018 Jun;15(3):294-302. doi: 10.1080/15412555.2018.1502264. Epub 2018 Sep 11. COPD. 2018. PMID: 30204492
-
Barriers to Prescribing Opioids in the Management of Chronic Breathlessness in COPD: A Review.COPD. 2021 Dec;18(6):713-722. doi: 10.1080/15412555.2021.2000956. Epub 2021 Nov 11. COPD. 2021. PMID: 34761726 Review.
-
Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD).BMC Pulm Med. 2021 Sep 10;21(1):289. doi: 10.1186/s12890-021-01647-8. BMC Pulm Med. 2021. PMID: 34507574 Free PMC article. Review.
Cited by
-
Prevalence and management of chronic breathlessness in COPD in a tertiary care center.BMC Pulm Med. 2019 May 16;19(1):95. doi: 10.1186/s12890-019-0851-5. BMC Pulm Med. 2019. PMID: 31096982 Free PMC article.
-
Opioids for the palliation of symptoms in people with serious respiratory illness: a systematic review and meta-analysis.Eur Respir Rev. 2024 Oct 9;33(174):230265. doi: 10.1183/16000617.0265-2023. Print 2024 Oct. Eur Respir Rev. 2024. PMID: 39384304 Free PMC article.
-
Attitudes to specialist palliative care and advance care planning in people with COPD: a multi-national survey of palliative and respiratory medicine specialists.BMC Palliat Care. 2018 Oct 15;17(1):115. doi: 10.1186/s12904-018-0371-8. BMC Palliat Care. 2018. PMID: 30322397 Free PMC article.
-
Analysis of end-of-life treatment and physician perceptions at a university hospital in Germany.J Cancer Res Clin Oncol. 2022 Mar;148(3):735-742. doi: 10.1007/s00432-021-03652-0. Epub 2021 May 5. J Cancer Res Clin Oncol. 2022. PMID: 33950342 Free PMC article.
-
Real-world opioid prescription to patients with serious, non-malignant, respiratory illnesses and chronic breathlessness.Intern Med J. 2022 Nov;52(11):1925-1933. doi: 10.1111/imj.15770. Epub 2022 May 31. Intern Med J. 2022. PMID: 35384242 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical